Abstract
This article provides a brief review of the control of medicines in the United Kingdom. The structure of the Medicines Commission and Statutory Advisory Committees is described as well as the procedure for reviewing applications for a New Drug Licence. The system of using Advisory Committees, Consultants and Academic Reviewers in the approval process is also discussed.
Get full access to this article
View all access options for this article.
